Jimenez Freddy A. 4
4 · Celldex Therapeutics, Inc. · Filed Aug 15, 2025
Insider Transaction Report
Form 4
Jimenez Freddy A.
SVP & GENERAL COUNSEL
Transactions
- Sale
Common Stock
2025-08-13$25.41/sh−430$10,928→ 34,962 total - Sale
Common Stock
2025-08-13$23.95/sh−341$8,167→ 35,392 total
Footnotes (1)
- [F1]Includes 269 shares of common stock acquired under the Celldex Therapeutics, Inc. 2004 Employee Stock Purchase Plan.